Progressive symptoms and signs following institution of highly active antiretroviral therapy and subsequent antituberculosis therapy: Immune reconstitution syndrome or infection?

Sexually Transmitted Infections

Volumn 82, Issue 2, 2006, Pages 111-116

  Miller, R F ^a   Shahmanesh, M ^b   Talbot, M D ^c   Wiselka, M J ^d   Shaw, P J ^e   Bacon, C ^a   Robertson, C M ^f  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Whittall Street Clinic ^*  (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^f Hospital of Coventry and Warwickshire   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; CLARITHROMYCIN; CYCLOSERINE; EFAVIRENZ; ETHAMBUTOL; GAMMA INTERFERON; ISONIAZID; LACTATE DEHYDROGENASE; LAMIVUDINE; MACROLIDE; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; FOLLOW UP; GENE; GENE MUTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERURICEMIA; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFECTION CONTROL; INFLAMMATORY DISEASE; LEUKOPLAKIA; MALE; MENTAL DISEASE; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PEER REVIEW; PRIORITY JOURNAL; RPOB GENE; SUICIDAL BEHAVIOR; THRUSH; TUBERCULOSIS; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; HIV-1; HUMANS; IMMUNE SYSTEM DISEASES; MALE; TUBERCULOSIS;

EID: 33645828029     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2005.019323     Document Type: Article

References (6)

1. Buckingham SJ, Haddow LJ, Shaw PJ, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy. Clin Radiol 2004;59:505-13.
2. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005;5:361-73.
3. Dheda K, Lalvani A, Miller RF, et al. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 2005;19:2038-41.
4. Pozniak AL, Miller RF, Lipman MC, er al. BHIVA treatment guidelines for tuberculosis(TB)/HIV infection 2005. HIV Med 2005;6(Suppl 2):62-83.
5. Llewelyn MJ, Noursadeghi M, Dogan A, et al. Diagnostic utility of bone marrow sampling in HIV-infected patients since the advent of highly active antiretroviral therapy. Int J STD AIDS 2005;16:686-9.
6. Whitely W, Tariq A, Peters B, et al. Pyrexia of undetermined origin in the era of HAART. Sex Transm Infect 2000;76:484-8.